Shares of Aventis SA, France’s No.1 drug maker, rose as much as 2.6% on optimism the government won’t oppose an effort by Switzerland’s Novartis AG to top Sanofi- Synthelabo SA’s €45.8 billion ($55 billion) hostile offer.